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SUMMARY 
Long-chain fatty acids are synthesized from citrate in an undialyzed soluble enzyme 
system from pigeon liver at a rate comparable to that observed when acetate is used 
as a precursor. The first enzymic step for citrate incorporation is probably its break- 
down to acetyl-CoA and oxaloacetate catalyzed by the citrate~cleavage enzyme. 
Experiments with variously labeled citrate show good incorporation of the acetyl 
portion of citrate into fatty acids, and a poor incorporation of the oxaloacetyl portion 
into fatty acids. The incorporation of the oxaloacetyl portion of citrate as well as the 
acetyl portion has b ~ n  shown to be avidin sensitive. The enzymic sequence from the 
oxaloacetyl portion remains uncertain. 
INTRODUCTION 
The biosynthesis of long-chain fatty acids from acetate is catalyzed by soluble 
enzymes of various tissues from several organisms x-e. We reported that citrate is as 
efficient a precursor of fatty acids as acetate in a pigeon-liver preparation ~. Similar 
results have also been obtained by KALLEN AND LOW, NaTure 8 using the lactating 
mammary gland of rats and by FORmCA 9. We postulated that the initial step in this 
biosynthesis is the cleavage of citrate to acetyl-CoA and oxaloacetate by the citrate- 
cleavage enzyme x° in the presence of ATP and CoA. 
Citrate + ATP + CoA-+ acetyl-CoA + oxaloacetate + ADP + Pv 
Acetyl-CoA is then incorporated into fatty acids through the malonyl-CoA pathway n, li. 
The fate of oxaloacetate formed form citrate is not yet clear. KALLEN AND LOW~NSTEXN s 
suggested that oxaloacetate might be involved in fatty acid biosynthesis via an alter- 
nate route. HOLSMAN is and ABRAHAM eta/. x4 have suggested a role of oxaloacetate or 
citrate in transcarboxylation reactions leading to malonyl-CoA .The present communi- 
cation presents further evidence that involves the citrate-cleavage enzyme in the con- 
version of citrate carbon into fatty acids. Data concerning the fate of the oxaloacetyl 
moiety of citrate in relation to fatty acid biosynthesis are also presented. 
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M E T H O D S  A N D  M A T E R I A L S  
ATP, CoA, NAD, NADH, NADP, NADPH, glucose 6-phosphate, hexokinase (EC 
2.7.I.I), glucose-6-phosphate dehydrogenase (EC i. i . i .49),  lipoic acid, thiamine 
pyrophosphate and avidin were obtained from commercial sources. 
Crystalline citrate-condensing enzyme (EC 4.1.3.7) was prepared by the method 
of S~ERE AND KOSICK115. Malate dehydrogenase (EC 1.1.1.37) was purchased from 
Boehringer and Sons. Crystalline fumarate hydratase (EC 4.2.1.2, formerly known as 
"fumarase") was a gift of Dr. T. P. SINGER. Citrate-condensing enzyme activity was 
measured by the method of OCHOA et aL an. Citrate-cleavage activity was measured 
according to the method of SRERE 10. Hexokinase, glucose-6-phosphate dehydrogenase 
and pyruvate oxidase (EC 1.2.3.3) activities were assayed spectrophotometrically 
following the procedures in Methods of Enzymology, Vol. I. Protein was estimated by 
the method of WARBURG AND CHRISTIAN 17. Citric acid was estimated by the colori- 
metric method of HARTFORD ls. 
Radioactive compounds 
Sodium [2-1*Clacetate, [I-a4Clacetic anhydride and [i,5-14Cz]citric acid were 
obtained from New England Nuclear Corporation. Ei-14ClFumaric acid and [2-14C] - 
fumaric acid were purchased from Nuclear Chicago Corporation. Sodium [I-14C1 - 
citrate, sodium [3,4-14C21citrate and sodium [5,6-x*C~]citrate were prepared as 
described below. 
Sodium [z-xaC]citrate: [I-14ClAcetyl-CoA was prepared from [I-14C]acetic an- 
hydride by the method of SIMON AND SHEMIN 10. [I-14ClAcetyl-CoA (1.5/,moles) was 
added to a reaction mixture (3 ml) containing 200/~moles of Tris-C1 buffer (pH 8.I), 
20/~moles of potassium malate, 4/~moles of NAD, 0.8 unit of malate dehydrogenase 
and I unit of citrate-condensing enzyme. The reaction was followed spectrophoto- 
metrically at 340 m/z and at the end of a half-hour was 95 % complete. 4 ° t~moles each 
of sodium acetate, sodium malate and sodium citrate were added as carrier and the 
reaction was stopped and partially deproteinized by heating to 7 °0 for 6 min. The 
organic acids were separated on a silicic acid column (21 × I cm) by  the method of 
VARNER 20. Effluent was collected in Io-ml fractions and t i trated with o.oi N NaOH 
with chlorophenol-red as indicator. Total radioactivity in each fraction was deter- 
mined. The appearance of acid ([I-14C]citric) corresponded with the appearance of 
radioactivity. The sodium EI-a4C!citrate was freed of the indicator by charcoal treat- 
ment at 60 ° for 5 min and the solution was concentrated on a flash evaporator. The 
Ei-~4Clcitric acid obtained was purified by rechromatography on silicic acid. 
Sodium E3,4-14C21citrate: For the enzymic synthesis of this compound 5 t ~moles 
of potassium E2,3-14C2]fumarate (7" l°6 counts/min) were added to 3 ml of a solution 
containing 5oo t~moles potassium phosphate buffer (pH 7-4), o-7 unit of malate 
dehydrogenase, o.6 unit of fumarate hydratase, 15 units of citrate-condensing enzyme, 
6 t~moles of acetyl-CoA and 9 t ~m°les of NAD. The rate and extent of formation of 
[3,4-14Cz]citrate was followed by the increase in absorbancy due to NADH formation 
at 34 ° mt~. Within 3 ° rain the reaction was virtually complete giving a conversion 
of around 6o % based on potassium fumarate added. 4 ° t~moles each of potassium 
fumarate, potassium malate and potassium citrate were now added. The sodium 
[3,4-14Cz]citrate was purified using the same procedure as for sodium ~I-x4C]citrate. 
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Sodium [5,6-14C2]citrate: For the enzymic preparation of this compound, the 
incubation mixture was the same as that  used for the preparation of [3,4-t~Cl]citric 
acid. The reaction, however, was started with 7 ~moles of potassium [I-t~C]fumarate 
(9" 1°6 counts/min) instead of potassium [2,3-14C~]fumarate. The sodium [5,6-14C2]- 
citrate was purified as described above. 
Preparation of the enzyme solution 
Fresh livers obtained from decapitated pigeons were minced and suspended in 
1. 5 vol. of a buffer solution 21 containing 8.5 ml of i M K~HPOI, 0. 9 ml of i M KH2PO 4, 
7 ml of I M KHCO 3 and I ml of i M MgClz in a total  volume of IOO ml. The tissue was 
homogenized by  four strokes of the pestle in a motor-driven Po t t e r -E lve jhem homo- 
genizer. The homogenate was centrifuged at 20000 × g for 20 min. The supernatant  
solution was then recentrifuged at IOOOOO × g for 9 ° min in a Spinco Model-L prepar- 
ative ultracentrifuge, and the resulting supernatant solution was used as the fa t ty  
acid-synthesizing enzyme system. 
Assay for fatty acid synthesis 
Long-chain fa t ty  acids were isolated from a copper-lime precipitate ~z according to 
the method of BRADY AND GURIN 23. At the end of the incubation period the reaction 
was stopped by  the addition of 0.5 lift of saturated KOH. I ml of absolute alcohol was 
added and the mixture was saponified at 95 ° for 45 min. The long-chain fa t ty  acids 
were precipitated as their copper salts with 0.2 ml of 20 % CuSO 4. 0.3 ml of IO % 
Ca(OH) 2 was added and the precipitate was washed thoroughly with water three times. 
The precipitate was suspended in I inl of water and the pH of this suspension was 
lowered to approx. 2 by  addition of 2 N HC1. The free fa t ty  acids thus formed were 
extracted into 5 ml of n-pentane by vigorous shaking for 2 min. An aliquot of the 
pentane solution was plated in aluminum cups and radioactivity determined in a gas- 
flow counter. 
Gas chromatographic analysis 
The fa t ty  acids were first converted to their methyl  esters with 2,2'-dimethoxy- 
propane following the procedure of RADIN et al. 2.. Carrier methyl  esters of myristate,  
palmitate and stearate were added and the methyl  esters were separated quantitat ively 
by  gas chromatography. The radioactivity in each fraction was determined in a liquid 
scintillation counter (Nuclear Chicago Company). 
RESULTS 
Incorporation of [r,5-14Ci]citrate into fatty acids 
The results shown in Table I and Fig. I allow one to compare the efficiency of 
citrate and acetate as precursors for long-chain fa t ty  acids. Since C-5 of citrate is not 
incorporated into fa t ty  acids (Table VII  below) the incorporation of C-I,5 labeled 
citrate is calculated on the basis of C-I alone. Thus under similar circumstances 
o.6I/~mole of acetate or 0.58/~mole of citrate are used for fa t ty  acid synthesis. The rate 
of incorporation of acetate and citrate into fa t ty  acids was similar. With increasing 
amounts of unlabeled acetate a decrease in counts in fa t ty  acids from sodium [I,5J4C2]- 
citrate was observed. Oxaloacetate lowers the incorporation of [i,5-14C,]citrate into 
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TABLE I 
INCORPORATION OF [I ,5-14C$]CITRATE AND [2-14C]ACETATE 
INTO FATTY ACIDS 
Each tube contained in a total  volume of 0.78 ml, 0.6 ml of enzyme (75 mg protein/ml), lO gmoles of 
magnesium fructose diphosphate, and the additions shown in the table. Tubes were flushed with N~ 
and incubated for 60 rain at  37 °. 
x4C -/abc/e.d 
l~ecta, soe Additions compound in- 
co,po, a t~  
(limoges) in fat ty  acids 
(a,,otes) 
- -  0.84 
0.5 0.70 
2.0 0.58 
Potassium [z,5-t4Cz]citrate Sodium acetate 1o.o 0.48 
zo gmoles 25.0 0.45 
75.0 o~4o 
Sodium [z-14C] acetate Potassium 
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Fig. L Rate of [14C]acetate and [t4CJcitrate incorporation into fat ty acids. Each tube contained in 
a total volume of 0.8 ml, 0.6 ml of enzyme (30 mg protein/ml) and 5 gmoles of magnesium fructose 
diphosphate. For the study of [2-14C]acetate incorporation, those tubes contained 3 #moles of 
[z-x4C]aceta, te (63 ooo counts/min) and zo pmoles of citrate ( 0 - - 0 ) .  For the study of rI,5-t4Ca]- 
citrate incorporation, these tubes contained io pmoles of tI,5-t4C~]citrate (300000 counts/rain) 
( O - - O  ). Temperature of incubation was 37 °. 
fatty acids but only at much higher concentrations (Table II). This dilution must be of 
C-I because C-5 of citrate is not converted to fatty acid carbon (Table VII). 
Effect of citrate-condensing enzyme 
Citrate-cleavage activity can be measured by trapping the acetyl-CoA formed 
with hydroxylamine and subsequently determining the amount of acetyl hydroxamate 
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T A B L E  I I  
EFFECT OF INCREASING CONCENTRATION OF ACETATE AND OXALOACETATE ON 
~I,5-14C2] CITRATE INCORPORATION 
I n  a tota l  vo lume  of  0 .85  ml, each tube  conta ins  0.55 ml  of e n z y m e  (47 m g  protein/ml) ,  5 / , m o l e s  of 
magnes ium fructose diphosphate ,  i o  pmole s  of potass ium [i ,5-14Cs]citrate (26oooo  counts /min) .  
Tubes  were  f lushed with  N~ for 3 o sec before incubat ion for 6o min  at  37 °. 
Potassium [x*C]Citmte incorpor- 
Expt. Sodium aceto2e oxa, leac2tate ated into fatty acids 
(~,motes) ( m.o~s) O, moles) 
I - -  - -  0 .33 
0.5 - -  0.30 
2.0 -- o.17  
i o . o  - -  o.13 
50.0  -- o.12 
100.0 -- O. IO 
IOO.O 0. 5 O. I I 
IOO.O 2.0 O.12 
100.O IO.O O.I 3 
IOO.O 50.0 O.IO 
lOO.O 1oo.o  0 .04  
2 -- 0. 5 0 .32 
- -  2 .0  0 .34 
- -  IO.O 0 . 3 0  
-- 50.0 o.21 
- -  IOO.O 0 .08  
-- I6O.O 0 . 0 6  
formed. If condensing enzyme is added to a citrate-cleavage system, hydroxamate 
formation is drastically reduced because the acetyl-CoA and oxaloacetate are con- 
verted to citrate faster than acetyl-CoA can react with hydroxylamine. In a system 
where acetyl-CoA production is used to assay the cleavage activity the addition of 
condensing enzyme would seem to inhibit the reaction. Increasing concentration of 
condensing enzyme should therefore decrease the incorporation of 14C from La4C] - 
citrate into fatty acids. Addition of crystalline citrate-condensing enzyme (pig heart) 
to the fatty acid-synthesizing system results in an 80 % reduction of [14C]citrate in- 
corporation (Table III). 
Effect of A TP and CoA 
A number of laboratories4,S,25, ~ have observed that low concentrations of citrate, 
ATP and CoA increase the incorporation of labeled acetate into fatty acids, but high 
concentrations result in a decreased incorporation. We feel the action of the citrate- 
cleavage enzyme explains these results. Initially citrate is needed for NADPH gener- 
ation (see below) while ATP and CoA are necessary for acetate activation. When the 
concentration of citrate, ATP or CoA is increased, then the amount of citrate cleaved 
is increased which lowers the quantity of citrate available for NADPH production 
and increases non-radioactive acetyl-CoA in the medium. Both these effects will 
reduce the radioactive acetate incorporated into fatty acids. 
5/~moles of ATP and CoA also reduce the incorporation of labeled citrate into 
fatty acids. This is presumably caused by removing a source of NADPH by increasing 
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TABLE III 
EFFECT OF CITRATE-CONDENSING ENZYME ON INCORPORATION OF 
[I,5-14C2]CITRATE INTO FATTY ACIDS 
Each  tube  conta ined in a to ta l  vo lume of 0.65 ml, 0. 5 ml of enzyme extrac t  (5 ° mg protcin/ml) ,  
5/~mol~s of nmgnes ium fructose d iphosphate  and lO/zmoles of sodium [1,5-i*C~lcitrate (260 ooo 
coun~ /min)  in addi t ion to vary ing  a m o u n t s  of condensing enzyme. Incuba t ion  was for 60 min a t  
37 °. Each  t u b e  was  flushed wi th  ni t rogen for 3 ° sec before s ta r t ing  the incubation.  
Condensing [14C]Citrate 
enzyme incorporated into 
(pmoles of fatty acids 
citrate fornwat/h) (pmoles) 







T A B L E  IV 
EFFECT OF ATP A N D  CoA ON INCORPORATION OF RADIOACTIVITY INTO 
FATTY ACIDS FROM [2-14C]ACETATE AND [I,5-14C2]ClTRATE 
In  addi t ion to  the  componen t s  shown in the table, each tube  contained o.6 ml of enzyme ext rac t  
(47 mg  prote in /ml)  and 5/~moles of magnes ium fructose d iphosphate  in a total  volume of 0.85 ml. 
The glucose 6-phosphate  regenerat ion sys tem for N A D P H  consisted of the following: glucose 
6-phosphate,  I0 /*moles ;  NADP,  0.2 pmoles ;  K 2 ATP, 2 pmoles ;  glucose-6-phosphate dehydroge- 
nase (0 .6 / /mole  of NAD reduct ion/min)  and crystalline hexokinase, o.2 mg. 
i4C-labeled compound 
A T P  CoA NADPH-regencrating incorporated into fatty 
Stdastre, te (l, moles) (t~moleM system acids (ttmoles) 
[2-14C]acetate, 2 pmoles  - -  - -  Sodium citrate, IO pmoles  0.64 
2 2 0.07 
5 5 o .oi  
20 IO 0.002 
[i,5-14C2]citrate, i o / , m o l e s  - -  - -  o.81 
2 2 o.37 
5 5 0-070 
5 5 Glucose 6-phosphate  sys tems  o.7o 
citrate cleavage, for when another NADPH-generating system is added then the in- 
corporation is increased to normal levels (Table IV). 
Fatty acid analysis 
A gas chromatographic analysis of the fatty acids synthesized from [I,5-I~C2] - 
citrate was undertaken in order to ascertain whether the composition of the fatty acids 
resembles the composition of fatty acids obtained from [2-14.C]acetate. The result of 
such an analysis is shown in Table V. The major fatty acids synthesized from labeled 
citrate are palmitate (66 %) and myristate (26 %). Incorporation into other fatty acids 
is small. A similar distribution of radioactivity into fatty acids synthesized from 
[2-*~C]acetate has been reported by PORTER AND TIETZ 27. 
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TABLE V 
GAS CHROMATOGRAPHIC A N A L Y S I S  OF F A T T Y  ACIDS 
SYNTH]~SIZZD FROM [14C]cITRATK 
This table shows a complete anslysis for the  fa t ty  acids in the  ~-pentane ext rac t  from an  incubat ion 
mixture  c o n ~ | n l n g  [i,5-1aCs]citric acid. 
Fr~r~ co~,V.slu 
n-Pentame extract  29 9o0 
Recovered as methyl  esters of fa t ty  acids 24 75 ° 
< Cx, 48o 
Cxt methyl  myris ta te  6 38o 
Cte methyl  pentadecamoate x4o 
Cte methyl  palmi ta te  x6 400 
Ct7 methyl  heptadecanoate  270 
C_~s methyl  s tearate  670 
> CIs 2to  
TABLE VI 
I N H I B I T I O N  OF F A T T Y  ACID S Y N T H E S I S  B Y  A V I D I N  
Each tube  contained in a to ta l  volume of I.Z5 ml, 0.8 ml of enzyme, x2.5 #moles of potassium 
citrate, 7-5 #moles of magnesium fructose diphosphate. A o . I %  solution of avidin in 0.02 M 
phosphate  butter  (pH 7.4) was used. The other  components axe shown below. Incubat ion  was for 
6o rain a t  37 ° after  N s flush. 
i , ~ m ~ / ~ o / a r t y  S~no~e (t~) ad~ (pw*e~) 
Sodium [2-14C] acetate - -  o.4i 
2.5 #moles, 20 0.29 
95 ooo counts/min 6o o. i2 
i5o  0.06 
300 0.02 
Potassium [I,5-xtCz]citrate m o.5 I 
xo #moles, 20 0.34 
I55 ooo counts/rain 60 o.I3 
I5O 0.05 
300 0.023 
Inhibition by avidin 
Table VI shows that avidin affects the incorporation of radioactivity from acetate 
and citrate into fatty acids to the same extent, which would imply that only the 
malonyl-CoA pathway was operative for citrate utilization. However, the inability of 
acetate to dilute out completely the acetyl-CoA pool from citrate (Table I) and the 
lowering of incorporation of radioactivity from labeled citrate by high concentrations 
of oxaloacetate (Table II) suggested that the oxaloacetyl moiety from citrate might 
give rise to malonyl-CoA by a route other than acetyl-CoA carboxylation or to fatty 
acids by a different mechanism. This was tested by using citrate labeled in the oxalo- 
acetyl portion of the molecule. 
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Incorpora¢ion of variously labeled citrates 
[I-14C]Citrate, [5,6-14C2]citrate, [3,4-14C2]citrate were compared as precursors for 
fa t ty  acid synthesis (Table VII). The cleavage enzyme has the same stereospecificity 
as the condensing enzyme, i.e., it breaks the citrate exactly at the same carbon to 
T A B L E  V I I  
INCORPORATION OF RADIOACTIVITY FROM VARIOUSLY LABELED CITRATES 
INTO FATTY ACIDS 
Each  tube  contains in a to ta l  volume of o.8 ml, 0.6 ml of enzyme (45 mg]ml  of protein) ,  5 pmoles  of 
magnes ium fructose d iphosphate  and Io pmoles  of var iously labeled po tass ium citrates as shown 
below. The tubes  were flushed wi th  N~ for 3 ° sec and incubated for 6o rain at  37 °. 
Radioactive citrate used Counts/rain used Counts/raiu in 
fatty acids 
[I,5-14C2]Citrate 12 360 47 ° ~: 20 
[i-14C]Citrate 12 400 920 :L 4 ° 
[3,4-xlCz]Citrate 12 54 ° 5 ° ~: 5 
[5,6-14C2]Citrate 12 5o0 o 
T A B L E  V I I I  
INCORPORATION OF [2-14C]FYRUVATE INTO FATTY ACIDS 
Each  tube  conta ins  in a to ta l  volume of 0.8 ml, 0.6 ml of enzyme (52 m g  protein/ml) ,  io /*moles  of 
po tass ium citrate, 5 / ,moles  of magnes ium fructose d iphosphate  and 3IOOOO counts / ra in  of 
Ez-x4CJpyruvate. 
Sodium Sodium ["CJPyruvate 
incorporated ~nto 
pyrumte acetate fatty acids 
(#~oles) (#~oles) (#raoles) 
0. 3 - -  0.0003 
5 - -  0.004 
50 - -  0.038 
0.3 2 0.0003 
5 2 0.004 
5 ° 2 o.o33 
T A B L E  I X  
AVIDIN INHIBITION OF FATTY ACID SYNTHESIS FROM 
L A B E L E D  CITRATES 
Each  tube  contains  in a total  volume of 1.2 5 ml, o.8 ml  of enzyme (5o mg  prote in/ml) ,  7.5/~moles of 
magnes ium fructose d iphosphate  and 12. 5 #moles  of po tass ium citrate.  
"C-/abeled 
Citrate u a e d  Coun~/rain/ Avidi~ i ~  
tube (l~g) into fatty acids* 
(reno,s) 
[ 1,5-14C~] Citrate I5 o ooo - -  0.90 
[I,5-14C2] Citrate I5o ooo 3oo 0.025 
[3,4-14Ca] Citrate 49 ooo - -  o.o3 
[3,4A4C2] Citrate 49 ooo 300 o.oox3 
* In  the  case of ~I,5-x4Ca]citrate this  refers to C-I only. However ,  in case of [3,4-x*C~]citrate 
bo th  C-3 and C- 4 are t aken  into account  (see text).  
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carbon linkage where it is formed (Bandurski and Topper, Bhaduri and Srere). These 
data show no incorporation of C- 5 or C-6; very slight incorporation of C-3 and C- 4 and 
good incorporation of C-I. When potassium [2-14C]pyruvate was tested as a precursor 
in comparable systems only 1/3 the activity found for C-3 and C-4 was found to be in- 
corporated (Table VIII). No pyruvate oxidase was found in the enzyme system. 
Avidin inhibited the incorporation of the radioactivity both from [i,5-14Cs]- and 
[3,4-14C2]citrates (Table IX). 
DISCUSSION 
The results using the variously labeled citrates for fat ty acid biosynthesis indicate 
that  only the acetyl-CoA moiety from citrate is incorporated into fat ty acids to a 
significant extent. Nonetheless a fraction of the oxaloacetyl portion of the molecule is 
also incorporated into fat ty acids. The lack of incorporation of C-5 or C-6 of citrate into 
fa t ty  acids eliminates a pathway in which oxaloacetate is oxidatively ~tecarboxylated 
to malonate with a subsequent incorporation into fat ty acids. 
The fact that  pyruvate was a poorer source of fat ty acid synthesis than oxalo- 
acetate would seem to eliminate a pathway where oxaloacetate gave rise to pyruvate 
(by transcarboxylation ~ or decarboxylation) which was then converted to acetyl-CoA 
and thence to fat ty acids. I t  is possible, however, that  pyruvate generated continuously 
during the incubation would be a better precursor than added pyruvate. There may 
exist a pathway in which oxaloacetate is converted to malonyl-CoA and thence to 
fat ty acids. Such an oxidative decarboxylation would be similar to those of pyruvate 
to acetyl-CoA or a-ketoglutarate to succinyl-CoA and one would predict the involve- 
ment of lipoate thiamine pyrophosphate, NAD and CoA, but not of biotin. Since 
the conversion is avidin sensitive this mechanism seems an unlikely one. Whatever the 
pathway, it does not seem to be quantitatively significant in the pigeon-liver system. 
MARTIN AND VAGELOS s9 have shown that  citrate stimulates the acetyl-CoA 
carboxylase (EC 6.4.1.2) reaction in rat adipose tissue preparations. This reaction is 
considered to be the rate-limiting step in fatt3~ acid biosynthesis s°, sl .It would seem 
likely that  part of the stimulatory effect of citrate observed with soluble enzyme 
systems is due to the activating effect of citrate on the carboxylating enzyme. Citrate is 
mostly localized inside the mitochondria ~ and the concentration of the extramito- 
chondrial citrate is considerably lower than what these authors l~se for the activation of 
the carboxylase enzyme. Since citrate can act as a carbon source, a source of hydrogen, 
and as an activator for carboxylase, the concentration of citrate outside the mito- 
chondria would be an important factor for regulating the fat ty acid biosynthesis in the 
whole cell. The problem of citrate transport across the mitochondrial membrane under 
various conditions needs to be thoroughly explored. 
Although for a number of years it has seemed unequivocal that  fat ty acid 
synthesis takes place chiefly in the cytoplasm a number of recent experiments have 
altered these views. HOLSMAN ~ and WAKIL et al.  3. have shown that  mitochondrial 
synthesis of fa t ty  acids occurs and ABRAHAM et al.  14 have implicated microsomal en- 
zymes in fat ty acid synthesis. These experiments have been done with isolated cell 
fractions and to date there is no information on the site of synthesis in intact cells. 
One must also consider the availability of substrates to the various parts of the cell. 
I t  is likely that  most of the acetyl-CoA formation of a cell takes place in the mito- 
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chondria therefore it must also be the precursor of cytoplasmic acetyl-CoA. This may 
occur in at least three ways: (a) by  diffusion of acetyl-CoA, (b) by  activation of acetate 
which has been formed in the mitochondria by deacylation of acetyl-CoA or (c) by 
cleavage of citrate which has been formed in the mitochondria and diffused out. 
Because of the distribution of citrate-utilizing and citrate-forming enzymes we feel the 
last possibility is an important  one. Citrate may indeed be the precursor of acetyl-CoA 
for fa t ty  acid biosynthesis in more physiological systems. Thus GORDON 15 has isolated 
labeled lipids from rats injected with ~14C~citrate and D'ADAMO AND HAFT 3~ have 
shown that  the isotope distribution in fa t ty  acids of livers perfused with [14C~gluta- 
mate indicates the operation of the citrate cleavage enzyme in their system. 
ACKNOWLEDGEMENT 
This work was gupported in part by  a grant from the National Institutes of Health 
(Grant No. A-2252). 
REFERENCES 
x R.  O. BRADY AND S. GUEIN, J. Biol. Chem., 199 (1952) 421. 
2 F. DITURI AND S. GURIN, Arch. Biochem. Biophys., 43 (I953) 23. 
3 S. J .  WAKIL, J .  w .  PORTBR AND D. M. GIBSON, Biochim. Biophys. Acts, 24 (I957) 453. 
4 A. TIETZ, Biochim. Biophys. Acts, 25 (1957) 303 . 
6 S. ABRAItAM, K.  J .  MAa'rHES AND I. L.  CHAIKOFF, J. Biol. Chem., 235 (196o) 2551. 
e S. ABRAHAM, K.  J.  MATTItBS AND I. L. CHAIKOFF, Biochim. Biophys. Ac~a, 49 (I961) 268. 
7 p.  A. S R B ~  AND A. BHADURY, BiocMm. Biophys. Acta, 59 (1962) 487 . 
s R .  G. K ~ L ~ N  AND J. M. LOWENSTEIN, Federation Proc., 2i  (1962) 289. 
9 j .  V. FORMICA, Biochim. Biophys. Acts, 59 (1962) 739. 
lO p. A. SRXBX, ]. Biol. Chem., 234 (1959) 2544. 
11 F.  LYNBN, FederaJion Proc., 20 (1961) 94 I. 
i i  S. J .  WAKIL, J. Lipid Res., 2 (196I) I. 
is W.  C. HOLSMAN, Nature, 192 (196I) I153. 
14 S. ABRAHAM, I. L. CHAIKOFF, W.  M. BORTZ, H.  P. KLEII~ AND H.  DEN, Nature, 192 (1961) 1287. 
15 p. A. SP, XBx AND G. KOSlCKI, J. Biol. Chem., 236 (1961) 2557. 
1' S. OCHOA, J. R .  STERN AND M. C. SCHNEIDER, •. Biol. Chem., 193 (1951) 691. 
tv O. WABBUBG AND W. CHRISTIAN,,~iochem. Z., 31o (1942) 384 . 
is C. G. HAETI~ORD, Anal. Chem., 34 (1962) 426. 
x0 E.  J .  SIMON AND D.  S~IEMIN, ]. Am. Chem. Sot., 75 (1953) 252o. 
20 j .  l~. VARNER, in S. P. COLOWICK AND N. O. KAPLAN, Methods in En~ymology, Vol. 3, Academic  
Press ,  New York,  1957, P. 397- 
21 R.  O. BRADY AND S. GURIN, Arch. Biochem. Biophys., 34 (1951) 22I.  
~l A. L. LBHNINGER AND S. W. SMITH, J. Biol. Chem., 173 (1948) 773. 
R.  O. Bm~.DY AND S. GURIN, J. Biol. Chem., 186 (I95o) 461. 
$4 N.  S. RADIN, A.  K. HAJRA AND Y. AKABORI, J. LipidRes., I (196o) 250. 
26 R. O. BRADY, A. M~MOON AND •. R.  STADTMAN, J .  Biol. Chem., 222 (1956) 795. 
E.  J.  MASORO, H.  M. I~ORCHAK AND •. PORTER, Biochim. Biophys. Acts, 58 (I962) 407 . 
~7 j .  W.  PORTER AND A. TIETZ, BiocMm. Biophys. Acts, 25 (1957) 4I .  
R. W. SwxcK AND H. G. WOOD, Proc. Nan. Acad. Sci. U.S., 46 (1960) 28. 
s9 D. B. MARTIN AND P. R.  VAOELOS, ] .  Biol. Chem., 237 (1962) I787. 
so S.. NUMA, M. MATSUHASHI AND F. LYNEN, Biochem. Z., 334 (1961) 2o3. 
81 j .  GANC;ULY, Biochim. Biophys. Aaa, 4 ° (I96o) n o .  
s2 W. C. SCHNXIDBR, M. J .  STRIBBICH AND E.  H.  HOGgBOOM, J. Biol, Chem., 222 (I946) 969. 
W.  C. HOI,SMAN, Biochim. Biophys. Acts, 58 (I962) 417. 
M S. J .  WAKIL, L.  W.  McLAIN, Jr .  AND J. B. WARSHAW, J. Biol. Chem., 235 (I96o) PC31. 
36 E.  E .  GORDOI% J. Clin. Invest., 4 ° (1961) I719. 
se A. F. D'ADAMO AND D. E.  HAFT, Federation Pgoe., 21 (1962) 6. 
Biochim. Biophys. Acts, 7 ° (1963) 221-23o 
